A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer-Reference-Cited by-同舟云学术

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer

Published:2009-01-22 Issue:4 Volume:64 Page:785-791
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Bozionelou Vasiliki,Kalbakis Kostas,Vamvakas Lambros,Agelaki Sofia,Androulakis Nikolaos,Kalykaki Antonia,Georgoulias Vassilis,Mavroudis Dimitris

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-0928-6.pdf

Reference34 articles.

1. Vogel CL, Azevedo S, Hilsenbeck S et al (1992) Survival after first recurrence of breast cancer: The Miami experience. Cancer 70:129–135

2. Hayes DF, Henderson IC, Shapiro CL (1995) Treatment of metastatic breast cancer: present and future prospects. Semin Oncol 22(Suppl 5):5–21

3. Valero V (1997) Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy. Semin Oncol 24/4(Suppl 13):11–18

4. Ravdin PM (1997) Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer. Semin Oncol 24/4(Suppl 10):18–21

5. Bissery MC, Guenard D, Gueritte-Voegelein F et al (1991) Experimental antitumor activity of Taxotere (RPR56976, NSC628503) a taxol analogue. Cancer Res 51:4845–4852

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer;Chemotherapy;2011